Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
SHINGRIX in immunocompetent people less than 50 years; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 19-year-old patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate age at vaccine administration (Verbatim: SHINGRIX in immunocompetent people less than 50 years). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 25-MAY-2025 The reporter inadvertently gave a 19 year old healthy patient a Shingrix vaccine. The reporter knew it could be given to immunocompromised situations. The reporter asked any information on response in healthy individuals. The patient received Shingrix below the recommended age schedule, which led to inappropriate age at vaccine administration.